Wednesday, November 18, 2026
FDA GUIDANCENovember 07, 2026

FDA Grants Premarket Approval (PMA P960009): Activa™ Deep Brain Stimulation Therapy System, Percept™ PC BrainSense™ (B32000) by Medtronic, Inc.

Affected Product:Activa™ Deep Brain Stimulation Therapy System, Percept™ PC BrainSense™ (B32000)
Recalling Firm / Manufacturer:Medtronic, Inc.
Reference / Recall Number:P960009
Executive Summary:

FDA awards Class III Premarket Approval (PMA P960009) for Activa™ Deep Brain Stimulation Therapy System, Percept™ PC BrainSense™ (B32000) sponsored by Medtronic, Inc..

The FDA Center for Devices and Radiological Health has granted Premarket Approval (PMA) for Activa™ Deep Brain Stimulation Therapy System, Percept™ PC BrainSense™ (B32000), classified as a Class III life-supporting or life-sustaining medical device.

PMA Approval Dossier

  • PMA Number: P960009
  • Applicant: Medtronic, Inc.
  • Device Designation: Activa™ Deep Brain Stimulation Therapy System, Percept™ PC BrainSense™ (B32000)
  • Product Code: MHY
  • Decision Code: APPR

Approval was based on rigorous review of valid scientific evidence, including bench testing, animal studies, and human clinical trial outcomes establishing a reasonable assurance of safety and effectiveness.

Official Regulatory Docket:Open Agency Docket